- Governor Ron DeSantis is poised to veto Florida’s Senate Bill 1698, a controversial measure that would have outlawed the sale of delta-8 THC and other federally legal hemp-derived cannabinoids.
- This strategic veto is reportedly intended to secure the hemp industry’s support in opposing Amendment 3, a November ballot initiative aimed at legalizing recreational marijuana.
- The decision underscores the deep political and economic chasm between Florida’s regulated medical marijuana sector and the burgeoning, often unregulated, hemp industry.
- For consumers and businesses across the state, this maneuver leaves the future of hemp-derived products and the broader landscape of cannabis legalization in a critical state of anticipation.
On June 4, 2024, Florida Governor Ron DeSantis is expected to execute a calculated political maneuver, vetoing Senate Bill 1698. This legislation, passed by both houses of the Florida state legislature on March 6, sought to prohibit the sale of delta-8 THC and a host of other federally compliant hemp-derived cannabinoids. The Governor’s impending decision, however, is far from a simple legislative rejection; it is a strategic play designed to influence the future of cannabis in the Sunshine State.
DeSantis’s Strategic Calculus: Leveraging Hemp Against Recreational Marijuana
Governor DeSantis, a vocal opponent of recreational marijuana legalization, views this veto as an astute tactical move. By preserving the legality of delta-8 and other hemp-derived products, he reportedly aims to garner the support of the established hemp industry in the fight against Amendment 3. This November ballot initiative seeks to amend the Florida Constitution, paving the way for adult-use recreational marijuana sales.
The veto is for voters and money—keep people from feeling the need to vote for marijuana and get the hemp industry to contribute the money to help fight the amendment.
This insight from an unnamed source close to the governor, as reported by CBS News Miami, illuminates the profound political chess match underway. DeSantis seemingly hopes that by maintaining access to intoxicating hemp products, voter enthusiasm for Amendment 3 will wane, while simultaneously mobilizing the financial resources of the hemp sector to actively campaign against the initiative.
Tired of the noise?
Join 152 other insiders for the weekly Lab Dispatch.
The Entrenched Battle: Hemp Versus Regulated Cannabis
The Florida cannabis landscape is characterized by a persistent tension between its regulated medical marijuana industry and its expansive hemp market. Proponents of SB 1698 primarily included medical marijuana businesses and external entities positioning themselves for entry into an adult-use market should Amendment 3 pass. These established players perceive the widespread availability of intoxicating hemp products—often sold over-the-counter in retail outlets—as direct commercial encroachment.
Had SB 1698 become law, it would have systematically outlawed the sale of popular hemp-derived cannabinoids such as delta-8 THC, HHC, delta-10 THC, THC-O, THCP, and THCV, alongside all synthetic cannabinoids. The bill also stipulated stricter allowable delta-9 THC levels, established 21 as the legal age for purchasing hemp products, and prohibited packaging that could be mistaken for food items or products “attractive to children”—measures some argue were a necessary step toward market regulation.
Economic Ripple Effects and Consumer Stakes
A ban on hemp-based products would have sent significant economic ripples throughout Florida, impacting numerous stakeholders in the nation’s third-most populous state. This includes hemp farmers, manufacturers, distributors, and a vast network of retailers, from vape shops to convenience stores. Beyond the commercial implications, a growing segment of Florida residents relies on hemp derivatives for managing anxiety and other medical conditions, and their access to these products would have been directly curtailed.
Nationally, roughly two dozen states have already imposed bans or restrictions on delta-8 THC and other hemp-derived cannabinoids, frequently with the backing of the regulated marijuana industry. In some jurisdictions, the sale of these intoxicating hemp products is confined exclusively to state-regulated marijuana dispensaries, illustrating a broader trend of market consolidation and control.
Defining the Lines: Hemp and the 2018 Farm Bill
The core of this debate often hinges on the federal distinction between hemp and marijuana, both varieties of the Cannabis sativa plant. Under the 2018 Farm Bill, hemp is legally defined as cannabis containing less than 0.3% delta-9 THC by dry weight and is regulated as an agricultural commodity. Cannabis plants exceeding this delta-9 THC threshold are classified as marijuana and remain federally illegal, creating a complex regulatory environment that Florida’s lawmakers continue to navigate.
Amendment 3: Florida’s Broader Cannabis Crossroads
The November ballot initiative, officially known as the Marijuana Legalization Initiative or Amendment 3, proposes to allow adults aged 21 and over to legally possess up to three ounces of marijuana and up to five grams in concentrated forms. Its passage would empower existing medical marijuana facilities to expand into recreational sales and grant the state legislature authority to license additional cultivation and retail businesses. Securing passage requires approval from 60% of voters, and recent polls have shown a mixed and uncertain outlook for the initiative.
As Governor DeSantis’s veto looms, the future of hemp-derived cannabinoids and the broader implications for marijuana legalization in Florida remain profoundly uncertain. This period of anticipation leaves both industries and the discerning consumer base awaiting clarity in a rapidly evolving market.
For further details and ongoing developments, Spinfuel recommends staying attuned to CBS News Miami and Marijuana Moment.